{
    "title": "U.S. FDA approves AstraZeneca-Merck's Lynparza to treat early-stage breast cancer",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10604501/U-S-FDA-approves-AstraZeneca-Mercks-Lynparza-treat-early-stage-breast-cancer.html",
    "date": "2022-03-11",
    "keywords": [
        "cancer",
        "drug",
        "breast",
        "astrazeneca",
        "merck",
        "lynparza",
        "chemotherapy",
        "approval",
        "march",
        "drugmaker",
        "plc",
        "food",
        "administration",
        "treatment",
        "form",
        "highrisk",
        "earlystage",
        "her2negative",
        "surgery",
        "latestage",
        "study",
        "improvement",
        "diseasefree",
        "survival",
        "risk",
        "death",
        "placebo",
        "class",
        "parp",
        "asset",
        "prostate",
        "world",
        "health",
        "organization",
        "payment",
        "reporting",
        "roy",
        "bengaluru",
        "editing",
        "daniel"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}